BEONE MEDICINES LTD. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
BEONE MEDICINES LTD. (ONC) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $797.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2024-08-07
- BEONE MEDICINES LTD. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2024-03-31 was $797.00K.
- BEONE MEDICINES LTD. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2023-09-30 was $5.52M, a 24.34% increase year-over-year.
- BEONE MEDICINES LTD. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2022-09-30 was $4.44M.
- BEONE MEDICINES LTD. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $6.45M.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|---|---|
| 2024-06-30 | $797.00K 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | $797.00K 10-Q · filed 2024-05-08 | ||
| 2023-12-31 | $6.45M 10-K · filed 2024-02-26 | ||
| 2023-09-30 | $5.52M 10-Q · filed 2023-11-09 | ||
| 2022-09-30 | $4.44M 10-Q · filed 2023-11-09 |